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to an Ancestral State
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Evgeny K. Ginter, and Evgeny I. Rogaev
We identified a mutation in the CRYGD gene (P23S) of the g-crystallin gene cluster that is associated with a polymorphic
congenital cataract that occurs with frequency of ∼0.3% in a human population. To gain insight into the molecular
mechanism of the pathogenesis of g-crystallin isoforms, we undertook an evolutionary analysis of the available mam-
malian and newly obtained primate sequences of the g-crystallin genes. The cataract-associated serine at site 23 corre-
sponds to the ancestral state, since it was found in CRYGD of a lower primate and all the surveyed nonprimate mammals.
Crystallin proteins include two structurally similar domains, and substitutions in mammalian CRYGD protein at site 23
of the first domain were always associated with substitutions in the structurally reciprocal sites 109 and 136 of the second
domain. These data suggest that the cataractogenic effect of serine at site 23 in the N-terminal domain of CRYGD may
be compensated indirectly by amino acid changes in a distal domain. We also found that gene conversion was a factor
in the evolution of the g-crystallin gene cluster throughout different mammalian clades. The high rate of gene conversion
observed between the functional CRYGD gene and two primate g-crystallin pseudogenes (CRYGEP1 and CRYGFP1) coupled
with a surprising finding of apparent negative selection in primate pseudogenes suggest a deleterious impact of recently
derived pseudogenes involved in gene conversion in the g-crystallin gene cluster.
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Cataracts are characterized by opaqueness of all or part of
the eye crystallin lens1 and are the most common cause
of blindness in the world, with congenital cataracts fre-
quently resulting in blindness or visual impairment in
children.2 The estimated prevalence is 2.2–2.49 cases per
10,000 live births,3 and ∼50% of all infantile cataract cases
are genetic.2 Most cases occur as isolated pathologies, but
some forms are associated with other abnormalities.4 Al-
though congenital cataracts can be transmitted as a re-
cessive or an X-linked trait, autosomal dominant inheri-
tance occurs most frequently and exhibits both clinical
variability and genetic heterogeneity.3
Clinical and molecular genetics studies have led to the
identification of multiple candidate disease loci for con-
genital cataracts. Mutations in genes encoding four spe-
cific types of proteins have been described in association
with the phenotype of nonsyndromic inherited cataracts.
These include members of the a-, b-, and g-crystallin
families5,6 (MIM 123580, 123590, *123610, *123620,
*123630, *123631, 600929, 123680, 123690, and
*123730), three transcription factors (MAF7 [MIM
*177075], PITX38 [MIM 602669], and HSF49 [MIM
*602438]), cytoskeletal protein BFSP210 (MIM *603212),
and membrane-transport proteins MIP1 (MIM 154050),
GJA3 (CX46)11 (MIM *121015), and GJA8 (CX50)12 (MIM
*600897). Approximately half of all mutations associated
with congenital cataracts are located in crystallin genes.13
Crystallins are the major water-soluble structural pro-
teins expressed in the mammalian eye lens and consist of
three major families—the a-, b-, and g- crystallins14—with
the g-crystallin composing up to 40% of the soluble pro-
teins expressed in the lens.15 In humans, the g-crystallin
gene cluster is located on chromosome 2q33-q35 and con-
sists of genes CRYGA (MIM *123660; GenBank accession
numbers M17315 and M17316), CRYGB (MIM *123670;
GenBank accession number M19364), CRYGC (MIM
123680; GenBank accession numbers K03003 and
K03004), and CRYGD (MIM 123690; GenBank accession
numbers K03005 and K03006)16 (encoding gA-, gB-, gC-,
and gD-crystallins, respectively), with cataract-associated
mutations in two of these genes (CRYGD and CRYGC) that
code for the most abundant g-crystallin proteins in the
lens.17 Two other g-crystallin genes—CRYGEP1 (GenBank
accession numbers K03007 and K03008) (encoding gE-
crystallin) and CRYGFP1 (GenBank accession numbers
K03009 and K03010) (encoding gF-crystallin) (both MIM
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Figure 1. Abridged PCC-affected pedigree selected from the genetic isolate. The mutation is transmitted as an autosomal dominant
trait. The affected individuals are represented by blackened squares (males) and circles (females), and the unaffected individuals are
represented by unblackened symbols. Family members participating in this study are indicated by an asterisk (*). One asterisk indicates
subjects genotyped by restriction enzyme–digestion analysis, and two asterisks indicate individuals genotyped by direct-sequencing
analysis.
*123660)—are also located in the same cluster. However,
in humans, they harbor a stop codon and are considered
pseudogenes, whereas, in other nonprimate mammals,
these genes appear functional.18 Cataractogenesis is antic-
ipated to be a strong factor in selection processes of genes
for lens proteins; however, very little is yet known about
the evolution of different members of g-crystallin genes,
especially in human and primate lineages. We have pre-
viously linked nonnuclear polymorphic congenital cata-
ract (PCC [MIM %601286]) to the g-crystallin gene cluster
(CRYG) on the human chromosome 3q33-35 in a large
pedigree from a Central Asian population.19 Here, we
screened the PCC-affected pedigree for mutations in the
CRYGA–CRYGD genes and performed an evolutionary and
structural analysis of the mutation and the g-crystallin
gene family.
Material and Methods
Mutation Analysis
The collection of DNA samples from subjects with PCC was de-
scribed elsewhere.19 The genomic sequence of human CRYGA–
CRYGD genes was obtained from the GenBank database.20 To
search for mutations, the protein-coding regions of these genes
were amplified by PCR, by use of genomic DNA from probands
of the PCC-affected pedigree. Pairs of oligonucleotide primers
flanking the exons of human CRYGA–CRYGD genes were de-
signed manually or by Primer3 and were used for PCR amplifi-
cation and sequencing of the PCR products (primer oligonucle-
otide sequences are available from the authors on request). PCR
was performed for 32 cycles at 94C for 3 min, with an annealing
temperature of 56C–58C for 30 s, and at 72C for 4 min. Each
PCR was performed in a volume of 25 ml that contained 10–20
pmol of each primer, 1# reaction buffer, 50 ng DNA, 200 mM
dNTP, 2.5–3 mM MgCl2, and 0.2 U Taq polymerase. The PCR
products were purified with electrophoresis in a 1% agarose gel,
1# TBE buffer, and the QIAEX II Kit gel extraction kit (QIAGEN).
The purified PCR products were sequenced directly with use of
an ABI Prism 310 Automated Sequencer with the ABI Prism Big-
Dye Terminator cycle sequencing kits (Applied Biosystems).
The C70T mutation in the CRYGD gene was initially found in
selected probands by direct sequencing. The presence or absence
of the mutation was elucidated further by restriction enzyme–
digestion assay in genomic DNA samples from all affected and
unaffected family members of the pedigree. To distinguish the
genotypes of unaffected and heterozygous individuals for this
particular mutation, we designed nucleotide substitutions in one
of the primers (reverse int) to create a new site for BpmI-restriction
endonuclease in the mutant C70T allele. Exon 2 of the CRYGD
gene was amplified by two rounds of PCR with the primers direct
ext (5′-GCAGCCCCACCCGCTCA-3′) and reverse ext (5′-GGGTA-
ATACTTTGCTTATGTGGGG-3′) and then with internal primers
direct int (5′-AGCCATGGGGAAGGTGAG-3′) and reverse int (5′-
AGTAGGGCTGCAGGCTGG-3′). The PCR products were digested
for 3–4 h at 37C with BpmI, and resulting DNA restriction frag-
ments were analyzed on a 7% polyacrylamide gel and were vi-
sualized using ethidium bromide staining. In total, we analyzed
54 individuals with cataract and 46 unaffected individuals from
the Middle Asian PCC pedigree. In addition, families with obesity
from the same genetic isolate (22 individuals) were genotyped.
We also tested 512 control chromosomes from white (206 chro-
mosomes from Russians) and mixed white and Mongolian (224
chromosomes from Tatars and 82 chromosomes from Bashkirs)
populations. The cataract-associated mutation (C70T) was de-
tected in affected individuals from the PCC-affected pedigree
only.
Sequencing of Primate Genes
To determine nucleotide sequences for ORFs of functional g-crys-
tallin genes (CRYGA–CRYGD) in primates, we used the PCR oli-
gonucleotide primers based on human sequences or redundant
oligonucleotide primers based on macaque, chimpanzee, and hu-
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Figure 2. Identification of the mutation in individuals with PCC.
A, The three exons (Ex) that comprise CRYGD. B and C, Sequence
chromatogram from a heterozygous patient carrying the P23S mu-
tation (B) and a homozygous wild-type sequence from an unaf-
fected individual (C). D, Exon sequence of CRYGD bearing the cat-
aract-associated PS23S mutation.
Figure 3. Sequence alignment of g-crystallins. The legend is
available in its entirety in the online edition of The American
Journal of Human Genetics.
man intronic sequences, such that these primers flanked exons
1, 2, and 3. The PCRs and sequencing were performed as described
above. The g-crystallin gene sequences were determined in species
of the following primate families: Hominidae (Pan paniscus [pygmy
chimpanzee, GenBank accession numbers EF467187, EF467196,
EF467205, and EF467214]; Pan troglodytes [chimpanzee, Gen-
Bank accession numbers EF467190, EF467199, EF467208, and
EF467217]; Gorilla gorilla [gorilla, GenBank accession numbers
EF467183, EF467192, EF467201, and EF467210]; Pongo pigmaeus
[orangutan, GenBank accession numbers EF467188, EF467197,
EF467206, and EF467215]); Hylobatidae (Hylobates lar [gibbon,
GenBank accession numbers EF467184, EF467193, EF467202,and
EF467211); Cecropithecidae (Macaca mulatta [rhesus monkey, Gen-
Bank accession numbers EF467186, EF467195, EF467204, and
EF467213]); Cebidae (Lagothrix lagotricha [common woolly mon-
key, GenBank accession numbers EF467185, EF467194, EF467203,
and EF467212]); Ateles geoffroyi [black-handed spider monkey,
GenBank accession numbers EF467182, EF467191, EF467200,
and EF467209]); and Callitrichidae (Saguinus labiatus [red-chested
mustached tamarin, GenBank accession numbers EF467189,
EF467198, EF467207, and EF467216]). In addition, we deter-
mined gene sequence for the putative pseudogene CRYGFP1 in
Pan paniscus (GenBank accession number EF492219), G. gorilla
(GenBank accession number EF492217), Pongo pigmaeus (Gen-
Bank accession number EF492220), and H. lar (GenBank accession
number EF492218). PCR primer oligonucleotide sequences are
available from the authors on request. Genomic DNA samples
were obtained from Coriell Cell Repositories and from our own
collection of primate DNAs.
Bioinformatic and Structural Analysis
In addition to the sequenced primate genes, we used the sequence
information of the g-crystallin genes from GenBank.20 We also
used the information on gene order from completely sequenced
mammalian genomes of Monodelphis domestica, Canis familiaris,
Mus musculus, and Bos taurus, using the UCSC Genome Browser.21
The rat genome (Rattus norvegicus) was excluded from the synteny
analysis because of a likely error of assembly of the g-crystallin
cluster. A multiple alignment of all sequences was made using
the MUSCLE alignment program.22 We reconstructed the phy-
logeny of the g-crystallin genes, using a Bayesean approach
as implemented in MrBayes, with 1 million iterations (mcmc
in MrBayes) with the General Time Reversiblengenp 1,000,000
model.23 Sequence divergence between genes was estimated using
the codeml program in the PAML package.24 Exon 1, which en-
codes 3 aa, was omitted from the phylogenetic analysis.
Results
A Novel Pathogenic Mutation in the GRYGD Gene
Elsewhere, we established a link between PCC and the
cluster of g-crystallin genes (CRYG) at chromosome 2q33-
35 in a large, unique pedigree of a family from a Central
Asian population.19 This population of mixed white and
Mongolian origin is characterized by tribe ancestry, high
endogamy, and complex ethnic genesis. Two inherited
monogenic diseases were accumulated in these popula-
tions: an autosomal dominant cataract (PCC), with fre-
quency of the mutant gene of ∼0.26%, and autosomal
recessive obesity, with frequency of the mutant gene of
∼2.47%.19,25,26 The large 7-generation PCC-affected pedi-
gree characterized by high endogamy and a high coeffi-
cient of inbreeding (13%) was selected for the molecular-
genetic study. Of the 157 pedigree individuals, 105 had
PCC, and DNA samples from 100 members, including 54
affected individuals, were available for mutation analysis
of the CRYG cluster (fig. 1).
We amplified and sequenced the coding regions of the
CRYGA–CRYGD genes and identified a novel nonsynon-
ymous C70T (P23S) mutation in the coding region of exon
2 of the CRYGD gene, which was found to cosegregate
with the disease (fig. 2). The presence or absence of the
mutation was confirmed by sequence analysis of four af-
fected and four unaffected individuals from the PCC-af-
fected pedigree and then by restriction enzyme–digestion
assay (as described in the “Material and Methods” section)
of DNA samples from all available members from the PCC-
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Figure 4. Sequence patterns in the interacting fragments of two
g-crystallin domains. Correlated serine and proline residues in CRYGD
are shown in red and green, respectively. H. sappH. sapiens; P.
trogpPan troglodytes; P. panispPan paniscus; P. pygpPongo pyg-
maeus; G. gorpG. gorilla; M. mulpMacaca mulatta; A. geofpA.
geoffroyi; L. lagotpL. lagotricha; S. labpS. labiatus; B. taurpB.
taurus; C. fampC. familiaris; R. norpR. norvegicus; M. muspMus
musculus.
Figure 5. Contact regions in two symmetrical crystallin domains
and four similar Greek key motifs form b-strands in two joined
protein domains. The sample is based on the structure of the human
gD-crystallin protein.
affected pedigree. All affected individuals—but none of
the related unaffected individuals from the PCC-affected
pedigree or other unaffected, unrelated control individ-
uals—were found to be heterozygous for this mutation.
Three common synonymous SNPs in CRYGB (C192T) and
CRYGD (T51C and T392C) were also detected. These poly-
morphic changes, however, showed no cosegregation with
PCC in this pedigree. We found no CRYGD C70T cataract-
associated mutation in unaffected individuals from the
same genetic isolate or in 512 control chromosomes from
populations of white or mixed white and Mongolian or-
igin (see the “Material and Methods” section). The data
strongly demonstrated that the nonsynonymous C70T
(P23S) substitution in CRYGD is the only mutation in the
g-crystallin gene cluster that segregates with PCC.
Compensatory Evolution Reveals Structural Characteristics
of the g-Crystallins
Mutations that have a pathogenic effect when they are
harbored in a human gene can be benign in other, some-
times closely related, organisms.27,28 Such cases are known
as “compensated pathogenic deviations” (CPDs), since it
is thought that the deleterious effect of such mutations is
neutralized by another, compensatory mutation. Unlike
mutations in g-crystallins described elsewhere, the mu-
tation we describe here also appears to be a CPD, such
that the disease-causing variant is found in the normal
CRYGD sequence of several wild-type organisms, includ-
ing one primate (fig. 3).
The basis of compensations of CPDs is usually the main-
tenance of structural stability within a single molecule,27–
30 although, in a few cases, the compensatory mutation
and the CPD may be located on two different interact-
ing proteins.27 To investigate the molecular nature of
the compensation of the P23S substitution, we assembled
sequences of the g-crystallin genes from the available
mammalian genomes (human, chimpanzee, macaque,
dog, mouse, rat, cow, and opossum) and the genew se-
quences for several primates that we determined in this
study (A. geoffroyi, S. labiatus, L. lagotricha, Macaca mulatta,
H. lar, Pongo pygmaeus, G. gorilla, Pan paniscus, and Pan
troglodytes). The resulting multiple alignment was ana-
lyzed on the basis of the available crystal structure of the
human CRYGD protein31 (Protein Data Bank ID 1h4a).
The b- and g-crystallin polypeptides fold into Greek key
motifs that form two structurally similar domains.31–33 On
the gD-crystallin structure, site 23 interacts with position
49, and, since many compensatory substitutions for CPDs
have been found in interacting sites, we surveyed the
amino acid at site 49 in mammalian gD-crystallin genes.
However, we found that site 49 and the neighboring sites
are generally conserved throughout evolution and show
no evidence of compensatory evolution with site 23 (fig.
4).
Thus, we undertook a correlation analysis in search of
compensatory substitutions in the entire gD-crystallin pro-
tein. We searched for the compensatory site on the basis
of the expected pattern of compensatory evolution27; that
is, all species harboring serine at site 23 must have a single
predicted compensatory amino acid at another site. No
single site conformed to this prediction. However, sites
109 and 136 conformed in conjunction, such that the
pathogenic state S23 was not observed together with the
human state in either site 109 or 136 (fig. 4). Thus, in the
course of evolution at site 23, in the common ancestor of
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Figure 6. Gene order of paralogous g-crystallin genes in mammalian genomes
primates, the ancestral serine changed to proline. In S.
labiatus, the proline reversed to the ancestral serine, ap-
parently without deleterious effects, whereas the same re-
versal in humans results in cataract formation. The dele-
terious effect of P23S substitution in humans is most likely
related to the P136S substitution that also occurred in the
primate, apparently the Hominidae-Hylobatidae common
ancestor. Interestingly, the amino acid is also reverted to
the ancestral state (S136P) in S. labiatus that have 23S in
the wild-type allele. In general, the presence of serine at
site 23 appears to be tolerated under the condition that
either site 109 or site 136 is occupied by a proline. Re-
markably, site 109 corresponds to the same position in the
second domain as site 23 in the first gD-crystallin domain,
whereas the corresponding site of the interaction site 49
in the second domain is site 137 (fig. 5).
Apparent Selection and Gene Conversion in the g-Crystallin
Gene Family
There is a large diversity of crystallin genes in higher an-
imals; the g-crystallin family is mammalian specific.34 The
g-crystallin family is located in tandem with one of the
genes (CRYGFP1) slightly removed from the rest of the
cluster (fig. 6). The high sequence similarity of some of
the g-crystallin genes in humans14 and a phylogenetic
analysis of the gene family in rats35 indicated that the g-
crystallin genes undergo gene conversion, which is ap-
parently restricted to exon 2.35 In addition, it is thought
that two of the six g-crystallin genes (CRYGEP1 and
CRYGFP1) have turned into a pseudogene in humans and
chimpanzees, as evidenced by the presence of stop codons
in the beginning of the second codon.14,18 Several diseases
are caused by gene conversion from a degenerate pseudo-
gene into a functional gene,36 including cataractogenesis
by gene conversion of the b-crystallin pseudogene to one
of the b-crystallin functional genes.37 The presence of
closely related pseudogenes in the g-crystallins coupled
with the reported gene-conversion events opens up the
possibility that the same mechanism is the cause of some
fraction of familial cataracts.
Gene conversion can make it particularly difficult to es-
tablish orthology38; therefore, we relied on synteny to re-
solve orthologous relationships within the g-crystallin gene
family. Indeed, the syntenic structure is well preserved
within the mammalian clade, with only one of the genes
(CRYGFP1) separated from an otherwise tandem arrange-
ment of the g-crystallin genes in the common ancestor of
placental mammals (fig. 6).
In rats, gene conversion appears to preferentially af-
fect the second exon of the g-crystallins.35 Thus, we con-
structed separate phylogenies for exons 2 and 3 for all six
of the g-crystallin genes for all available mammals, which,
for the first time, included primates (fig. 7). On a phylog-
eny, gene-conversion events appear at a point of com-
mon ancestry of paralagous sequences.38 In exon 2, gene
conversion was found across all of the genes in the g-
crystallin family and in all surveyed taxa, but it was par-
ticularly common in nonprimate mammals and in
CRYGD, CRYGEP1, and CRYGFP1 (fig. 7A).
Since the divergence of the macaque and human lin-
eages, there have been at least two fixed gene-conversion
events in the macaque genome (one between CRYGEP1
and CRYGFP1 and one between CRYGD and the precon-
verted CRYGE or CRYGFP1 sequence). In the human-chim-
panzee lineage, there have been a gene-conversion event
between CRYGE and CRYGFP1 after the macaque split and
a probable gene-conversion event around the time of di-
vergence from macaques (fig. 7A). The rate of gene con-
version in primates appears to be higher in CRYGEP1,
CRYGFP1, and CRYGD, since only one gene-conversion
event involving other genes (between CRYGB and CRYGC)
was fixed around the time of divergence of the surveyed
primate species (fig. 7A). The rate of gene conversion in
exon 3 was not as high as in exon 2, but some conversion
events were still observed (fig. 7A). Exon 3 of CRYGEP1
and CRYGFP1 was involved in at least five gene-conversion
Figure 7. Bayesian phylogenies of exon 2 (A) and exon 3 (B) of the g-crystallins. Gene-conversion events are shown on the phylogeny
with a blackened square, and only posterior probabilities !0.90 are indicated. A, B, C, D, E, and F correspond to the CRYGA, CRYGB,
CRYGC, CRYGD, CRYGE, and CRYGF genes, respectively.
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Table 1. Sequence Divergence between Human and
Macaque g-Crystallin Genes
Gene
No. of Substitutions
dn:dsa PbNonsynonymous Synonymous
CRYGA 4.12 6.25 .1338 !.05
CRYGB 7.22 14.93 .1001 !.001
CRYGC 5.16 5.08 .1953 NS
CRYGD 9.32 4.31 .3322 NS
CRYGEP1 11.46 15.12 .1041 !.001
CRYGFP1 21.22 17.06 .2236 !.01
a The rate of synonymous (ds) and nonsynonymous (dn) evolution.
b The P value of a x2 test of the number of synonymous and nonsy-
nonymous substitutions observed compared with the number expected
under neutrality. NSpnot significant.
events since the radiation of placental mammals: two in
rodents, one each in dog and cow, and one in primates
before the divergence of humans and macaques.
The relatively high rate of gene conversion in primates
that involves two of the genes that have been pseudo-
genized in humans and a functional gene reveals the pos-
sibility that some of the degenerate mutations that have
accumulated in the pseudogene may be transferred to the
functional gene, with deleterious or pathogenic conse-
quences. Such frequent gene conversion between a pseu-
dogene and a functional gene should lead to a pattern of
negative selection in the pseudogene, because selection
would act against degenerate mutations in the pseudogene
if gene conversion events frequently transfer such muta-
tions to a functional gene.39,40
Although CRYGEP1 and CRYGFP1 are thought to be pseu-
dogenes in humans and chimpanzees,18 it is not known
whether they are functional in other primates. We retrieved
the macaque CRYGEP1 and CRYGFP1 sequences from or-
thologous (determined by synteny) sections of the ma-
caque genome, and we compared the obtained sequences
with those of other g-crystallin genes from different spe-
cies. The macaque CRYGFP1 sequence contained three
frameshift mutations, strongly suggesting that it is a pseu-
dogene. The functional status of CRYGEP1 was not as ap-
parent. Although the macaque CRYGEP1 gene showed
seven amino acid changes in evolutionarily conserved
sites in all g-crystallins, no inframe stop codons or frame-
shift mutations were observed.
A common way to test the strength of selection acting
on protein-coding genes is to compare the rate of syn-
onymous (ds) and nonsynonymous (dn) evolution.38 A
neutrally evolving sequence, such as a pseudogene, is ex-
pected to show the same rate of evolution in these two
types of sites ( ). We compared the rates of ev-dn:dsp 1
olution between human and macaque sequences for all
six genes in the g-crystalline cluster (table 1). We found
no evidence to support a neutral level of evolution in
CRYGEP1 ( ) that would suggest that CRY-dn:dsp 0.1041
GEP1 is an active gene in the macaque; however, we also
found that the dn:ds ratio significantly differs from 1 even
for the CRYGFP1 pseudogene ( ). Such ap-dn:dsp 0.2236
parent selection is commonly observed on the phenotypic
level41; however, to our knowledge, it has been observed
only once on a molecular level, in a mouse c-ubiquitin
cluster by an uneven crossing-over event.42 We determined
the CRYGFP sequence in Pan paniscus, Pongo pygmaeous,
and H. lar and found signs of pseudogenization of the gene
in different primate species (table 2) (see the “Discussion”
section). To our knowledge, this is the first study that ob-
serves apparent selection in nonfunctional sequence due
to gene conversion with a functional gene.
Discussion
To date, six different mutations in the CRYGD gene
have been found in patients with cataracts: R14C,43
R36S,44,45 R58H,46 W156X,47 P23T,47 and E107A48 (MIM
123690.0001–123690.0006). The seventh mutation iden-
tified here (P23S) appears to be the cause of the nonnuclear
PCC. This mutation is accumulated in an isolated popu-
lation (with frequency of ∼0.26%) along with autosomal
recessive obesity (with frequency of the mutant-gene allele
of ∼2.5%). We found no connection or cosegregation of
these pathologies, which were probably inherited from
different ancestral founders. The PCC type of cataract is
characterized by a nonprogressive phenotype and partial
opacity of the lens, which has a variable location on the
periphery between the fetal nucleus of the lens and the
equator. The opacities are irregular and look similar to a
bunch of grapes or a lump of cotton balls and may be
present simultaneously in different lens layers.19 Another
amino acid substitution at the same site has been described
elsewhere, a prolinerthreonine substitution (P23T) in a
family with congenital cataracts.47,49–53 Generally, the clin-
ical manifestation of the PCC-affected family was different
from that of patients with other forms of familial cataracts
caused by the P23T mutation of the CRYGD gene. The
P23T mutation has been shown to cosegregate with var-
iable phenotypes, such as the lamellar cataract in an In-
dian family and the fasciculiform, coralliform, and ceru-
lean cataracts (MIM 608983) in a Moroccan family.47,49–53
The segregation frequency of PCC strongly corresponds
to an autosomal dominant form of inheritance (frequency
[SD] of 0.560.04) with 190%–97% penetrance.19,25
Thus, the variability of clinical phenotype may be caused
by epigenetic factors during embryonic development or
by gene modifiers.
In vitro experimental data about the nature of the P23T
substitution suggested that this change does not sig-
nificantly alter the stability structure of the protein but,
rather, affects the protein solubility,32,33 resulting in clus-
ters of the P23T-mutant protein. Because of a high simi-
larity of the side chains of thrionine and serine, Evans et
al.32 also considered the impact of a nonnatural P23S sub-
stitution and found that P23S also affects the solubility of
gD-crystallin, although not as profoundly. This effect may
be caused by a change in the hydrogen-binding charac-
teristics of the protein-water interface. A substitution of a
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Table 2. Signs of Pseudogenization in the Primate CRYGFP1 Pseudogene
Species Sign(s) of Pseudogenization
H. sapiens 56 YrSTOP and 1-nt deletion at site 422
Pan troglodytes 56 YrSTOP, 1-nt deletion at site 422 and deletion of the 5′ end of exon 3 sites 252–267
Pan paniscus 56 YrSTOP, 1-nt deletion at site 422, deletion of the 5′ end of exon 3 sites 252–267, and A insertion at site 455
G. gorilla 56 YrSTOP
Pongo pygmaeus 42 CrSTOP
H. lar Second intron splice sites AT…GG
Macaca mulatta 1 MrK, G deletion at site 30, 28-nt insertion at site 425, and 4-nt insertion at site 511
proline, since it is an imino acid that does not have a
hydrogen bond–forming NH group, is particularly capable
of affecting solubility in water. Thus, it is likely that the
P23S substitution is compensated for in another part of
the gD-crystallin protein.
This observation is in agreement with our observation
that the probable compensatory substitution is a reversal
to a proline in structurally reciprocal sites in a different
domain. The distribution patterns of the proline/serine
residues that we describe here may play an important role
in the protein-water–system stabilization. In particular,
these sites can be the part of the crystallin interaction
interface with other lens proteins where, possibly,gD-crys-
tallins are connected with each other. Substitutions in
these sites may lead to protein aggregation in solution that
dramatically changes the lens crystal transparency. The
observation that two sites, 109 and 136, may compensate
for the same CPD (P23S) is not completely unexpected,
since examples of compensatory interactions involving
more than two interacting sites have been described.28,29
We find evidence to support active gene conversion
between the pseudogene CRYGFP1 and the functional
CRYGD gene copy in recent evolution (since the diver-
gence of human and macaque lineages). In addition, we
find that a conversion event between these two genes also
occurred sometime in the primate lineage before the di-
vergence of humans and macaques (fig. 7). The phylogeny
can reveal only fixed gene-conversion events, such that,
if gene conversion events still occur but are not fixed, they
will not be observed. In particular, the probability of fix-
ation of a gene-conversion event will be much lower if it
brings a deleterious substitution into a functional gene.39,40
Thus, gene conversion between the pseudogenes and the
functional gene copies may have occurred with a much
higher frequency on a mutational level than is apparent
from the phylogeny that reveals only fixed events on an
evolutionary scale.
The observation of apparent negative selection in pseu-
dogenes depends on the assumption that these genes be-
came pseudogenes before the divergence of humans and
macaques. There are no shared stop codons or frameshift
mutations between the human and macaque pseudogenes;
however, frequent gene conversion, which is seen between
these pseudogenes and their functional copies, will erase
such shared stop codons. To demonstrate this point, we
sequenced the CRYGFP1 pseudogene from Pan paniscus,
G. gorilla, Pongo pygmaeus, and H. lar, in addition to an
already available sequence from H. sapiens, P. troglodytes,
and Macaca mulatta. We found that the CRYGFP1 sequence
is a pseudogene in each of these species; however, whereas
the higher ape species share a stop codon, other species
show different signs of pseudogenization (table 2). The
possibility of very recent and independent pseudogeni-
zations of the same gene in four separate lineages is ex-
tremely remote and is unlikely to explain our observations.
There are two nonexclusive ways in which gene con-
version between a functional gene and a pseudogene can
lead to apparent negative selection. The first is gene con-
version of the functional sequence over that of the pseu-
dogene. A comparison of pseudogene sequences from two
species would reveal apparent negative selection ( )dn ! ds
if such gene-conversion events were fixed after the diver-
gence of the two species. Alternatively, selection may act
on mutations in the pseudogene if such mutations are
deleterious when they are converted to the functional gene.
Whereas the first model is simple and requires only one
fixed gene conversion of a functional copy to the pseu-
dogene, the latter model encompasses many parameters,
such as mutation rate and gene-conversion rate, on a pop-
ulation level. To delineate the exact conditions under
which gene conversion from a pseudogene to a functional
gene can lead to apparent selection in a pseudogene, we
would require an extensive population genetics model,
which is beyond the scope of our work here. However, it
is clear that, for apparent selection to show such a strong
pattern of selection (dn:ds for the pseudogene gF-crystal-
lin was very similar to dn:ds for other functional CRYG
genes and substantially deviates from a neutral expecta-
tion of ; see table 1), the rate of gene conver-dn:dsp 1
sion should be at least on the order of the rate of emer-
gence of the potentially deleterious substitutions in the
pseudogene.
Since we observe apparent selection in the pseudogene,
it is reasonable to hypothesize that some mutations that
may cause cataracts in humans may originate in func-
tional genes from gene-conversion events from either the
CRYGEP1 or the CRYGFP1 pseudogene. Indeed, the acti-
vation of the CRYGEP1 pseudogene may lead to Coppock-
like cataracts,16 and gene conversion leading to genetic
disorders has been observed for several diseases,36 includ-
ing cataract formation through gene conversion in the b-
crystallins.37 The observation that the CRYGD gene has
the most cataract-causing mutations described in humans
(including P23T) of all functional CRYG genes3 may be
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explained either by a higher level of expression of the
CRYGD gene compared with the other CRYG genes18 or
by a higher rate of gene conversion of CRYGD with pseu-
dogenes, which may harbor such mutations.
We checked the sequence of mutations known to cause
cataracts in humans against those of the two pseudogenes
(fig. 3). Of the seven surveyed mutations, we found one
that corresponded to a state found in a pseudogene—P23T
in CRYGD, which is the most common and likely inde-
pendently derived mutation underlying clinical heteroge-
neity for different forms of cataracts. It is unclear whether
this or other mutations also originate through gene con-
version. Nevertheless, our evolutionary analysis suggested
that negative selection of g-crystallin pseudogenes is likely
driven by gene conversion of the pseudogenes with func-
tional genes that may result in cataractogenic g-crystallin
alleles.
We describe a human polymorphic congenital cataract
caused by a mutation that reversed an amino acid in the
CRYGD gene to an ancestral state found in nonprimate
mammals. This cataract-associated mutation may be com-
pensated for by indirect mechanisms related to the overall
protein solubility, through substitutions in a symmetric
protein domain. In addition, we found gene-conversion
events in the g-crystallin gene cluster in several mam-
malian species that involve the interaction of pseudogenes
and functional genes in the primate lineage. The observed
negative selection in the pseudogene in the course of hu-
man-macaque divergence is likely to be the result of ap-
parent selection due to frequent gene conversions be-
tween the pseudogenes and the functional genes. The data
suggest that some cataractogenic mutations might appear
in functional g-crystallin genes from pseudogenes through
gene-conversion events contributing to conservation of
the pseudogene sequence.
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Web Resources
Accession numbers and URLs for data presented herein are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for sequence
information on CRYGA [accession numbers M17315 and
M17316], CRYGB [accession number M19364], CRYGC [acces-
sion numbers K03003 and K03004], CRYGD [accession numbers
K03005 and K03006], CRYGEP1 [accession numbers K03007
and K03008], and CRYGFP1 [accession numbers K03009 and
K03010]; Pan paniscus CRYGA, CRYGB, CRYGC, CRYGD, and
CRYGFP1 [accession numbers EF467187, EF467196, EF467205,
EF467214, and EF492219, respectively]; Pan troglodytes CRYGA,
CRYGB, CRYGC, and CRYGD [accession numbers EF467190,
EF467199, EF467208, and EF467217, respectively], G. gorilla
CRYGA, CRYGB, CRYGC, CRYGD, and CRYGFP1 [accession
numbers EF467183, EF467192, EF467201, EF467210, and
EF492217, respectively]; Pongo pygmaeus CRYGA, CRYGB,
CRYGC, CRYGD, and CRYGFP1 [accession numbers EF467188,
EF467197, EF467206, EF467215, and EF492220, respectively];
H. lar CRYGA, CRYGB, CRYGC, CRYGD, and CRYGFP1 [acces-
sion numbers EF467184, EF467193, EF467202, EF467211, and
EF492218, respectively]; Macaca mulatta CRYGA, CRYGB,CRYGC,
and CRYGD [accession numbers EF467186, EF467195,
EF467204, and EF467213, respectively]; L. lagotricha CRYGA,
CRYGB, CRYGC, and CRYGD [accession numbers EF467185,
EF467194, EF467203, and EF467212, respectively]; A. geoffroyi
CRYGA, CRYGB, CRYGC, and CRYGD [accession numbers
EF467182, EF467191, EF467200, and EF467209, respectively];
and S. labiatus CRYGA, CRYGB, CRYGC, and CRYGD [acces-
sion numbers EF467189, EF467198, EF467207, and EF467216,
respectively])
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for PCC and other genetic forms of
cataracts)
Primer3, http://frodo.wi.mit.edu/
Protein Data Bank, http://www.pdb.org/ (for the human CRYGD
protein [ID 1h4a])
University of California Santa Cruz (UCSC) Genome Browser,
http://genome.ucsc.edu/
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